retatrutide: Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide Delivers Significant Hemoglobin A1C
Description
other hypoglycemics for patients with type 2 diabetes

Cells 11 , 1883 (2022)

GLP-1 receptor agonists like Ozempic , Wegovy , Mounjaro , and Zepbound are transforming how we approach weight loss, blood sugar control, and metabolic health

efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1) Diabetes Care

For many, that can include the need for a weekly subcutaneous injection
